From: Simple, sensitive and rapid determination of linifanib (ABT-869), a novel tyrosine kinase inhibitor in rat plasma by UHPLC-MS/MS
Nominal concentration (ng/mL)
Percentage recovery
Linifanib (Analyte)
1.28
82.5
42.5
67.3
425
65.7
71.8 ± 9.2
Sunitinib (IS)
100.0
75.1